Is RNAZ or RVPH more undervalued in 2026?

CirclFi compares TransCode Therapeutics, Inc. (RNAZ) and Reviva Pharmaceuticals Holdings (RVPH) using 13 institutional-grade valuation models. RNAZ has a Quality of Company score of 3.9/10 while RVPH scores 3.7/10.

Which is a better buy — RNAZ or RVPH?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RNAZ and RVPH valuations compare?

RNAZ at $5.14 and RVPH at $0.40 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RNAZ vs RVPH Valuation Comparison 2026 — Intrinsic Value Analysis

RNAZ

Pharmaceutical Preparations

TransCode Therapeutics, Inc.

Quality

3.9

out of 10

Value Trap

LOW

Price

$5.14

Last close

Models

6/13

Active

RVPH

Pharmaceutical Preparations

Reviva Pharmaceuticals Holdings

Quality

3.7

out of 10

Value Trap

SAFE

Price

$0.40

Last close

Models

5/13

Active

Model-by-Model Comparison

Model	Type	RNAZ Fair Value	RNAZ Upside	RVPH Fair Value	RVPH Upside
Bayesian DCF	Intrinsic	$9.29	+80.8%	$1.02	+153.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.13	-98.4%	$0.03	-96.6%
PWERM	Option-Based	$18.92	+268.1%	$0.75	+88.2%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RNAZ vs RVPH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RNAZ vs RVPH — Which Stock Is More Undervalued?

RNAZ scores higher with a 3.9/10 quality rating vs RVPH's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing TransCode Therapeutics, Inc. (RNAZ) and Reviva Pharmaceuticals Holdings (RVPH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RNAZ currently trades at $5.14 with a QOC of 3.9/10, while RVPH trades at $0.40 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).